Quantitative comparison of DNA methylation assays for biomarker development and clinical applications

Christoph Bock(Austrian Academy of Sciences), Anders O.H. Nygren(Asana Biosciences (United States)), Kun Zhang(The University of Texas MD Anderson Cancer Center), Manel Esteller(Institució Catalana de Recerca i Estudis Avançats), Dinh Diep, Christina Dahl(Danish Cancer Society), Florian Halbritter(Austrian Academy of Sciences), Lise Lotte Hansen(Aarhus University), Mihaela Campan(University of Southern California), Kimberly Walter(Johns Hopkins University), Stephan Beck(London Cancer), Frank Reinicke(Qiagen (Germany)), José I. Martín‐Subero(Institució Catalana de Recerca i Estudis Avançats), Guido Sauter(Universität Hamburg), Andrea Haake(Christian-Albrechts-Universität zu Kiel), Dirk S. Paul(AstraZeneca (United Kingdom)), Peter W. Laird(Van Andel Institute), Paul Datlinger(Palo Alto Institute), Rocío G. Urdinguio(Universidad de Oviedo), Ana C. Queirós(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Katharina Heilmann(German Cancer Research Center), Agustín F. Fernández(Universidad de Oviedo), Daniel J. Weisenberger(University of California, Los Angeles), Susan J. Clark(University of Sheffield), Per Guldberg(University of Southern Denmark), Anke Bergmann(Instituto Nacional de Câncer - INCA), Marta Kulis(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Sascha Tierling(Epigénétique et Destin Cellulaire), Virginia López(Universidad de Oviedo), Aaron L. Statham(Garvan Institute of Medical Research), Mitsuteru Ito(University of Cambridge), Nongluk Plongthongkum, Dieter Weichenhan(German Cancer Research Center), Keith Booher, María Berdasco(Institut d'Investigació Biomédica de Bellvitge), Mario F. Fraga(Centre National de la Recherche Scientifique), Ruslan Strogantsev(Oregon Health & Science University), Yassen Assenov(Max Planck Institute for Informatics), Dianna Hussmann(Aarhus University), Florence Busato(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Christina M. Dahmcke(Danish Cancer Society), Anne C. Ferguson‐Smith(University of Cambridge), Ruth Kläver(Qiagen (Germany)), Martin Kreutz(Qiagen (Germany)), Thomas Holcomb, Francisco javier García Carmona(Institut d'Investigació Biomédica de Bellvitge), Shalima S. Nair(Garvan Institute of Medical Research), Clare Stirzaker(Garvan Institute of Medical Research), Wenjia Qu(Garvan Institute of Medical Research), Thorsten Schlomm(Charité - Universitätsmedizin Berlin), Clarissa Gerhäuser(German Cancer Research Center)
Nature Biotechnology
June 27, 2016
Cited by 347


Related Papers